ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      16,978.00
      0.00%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.45
      0.34%
      Bitcoin
      64,296.35
      -0.29%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Opko Health Inc (OPK)

      7. Opko Health Inc (OPK) News

      OPK Opko Health Inc

      1.22
      0.00 (0.00%)
      Apr 25 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Opko Health Inc OPK NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 1.22 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      1.22
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      3/28/202408:00PRNUSLabcorp Announces Acquisition of Select Assets of..
      3/20/202408:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
      3/07/202416:02EDGAR2Form ARS - Annual Report to Security Holders
      3/05/202408:52GLOBEAIDS Clinical Trial Group Presents Results from Phase 1..
      3/01/202416:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
      2/28/202409:31PRNUSNextPlat Opens OPKO Health-Branded Storefront on Alibaba's..
      2/27/202416:07EDGAR2Form 8-K - Current report
      2/27/202416:05GLOBEOPKO Health Reports Fourth Quarter 2023 Business Highlights..
      2/22/202416:05GLOBEOPKO Health to Report Fourth Quarter 2023 Financial Results..
      2/16/202416:53EDGAR2Form PRE 14A - Other preliminary proxy statements
      2/09/202416:07EDGAR2Form 8-K - Current report
      2/05/202408:09PRNUSNextPlat Receives Initial Approvals to Launch OPKO..
      1/29/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202416:15EDGAR2Form SC 13D/A - General statement of acquisition of..
      1/24/202416:00EDGAR2Form 8-K - Current report
      1/17/202417:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/10/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202417:09EDGAR2Form 8-K - Current report
      1/09/202416:05GLOBEOPKO Health Announces Closing of Private Offering of $230..
      1/08/202409:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202408:00GLOBEOPKO Health to Present at the 42nd Annual J.P. Morgan..
      1/05/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202413:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202412:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202407:00EDGAR2Form 8-K - Current report
      1/04/202423:31GLOBEOPKO Health Announces Pricing of Private Offering of $200..
      1/03/202417:05GLOBEOPKO Health Announces Private Offering of Convertible Senior..
      11/28/202307:00PRNUSBioReference Health and Prognos Health Collaborate to..
      11/13/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/13/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/07/202306:45PRNUSBioReference® Signs On as the First Laboratory to Use..
      11/06/202316:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/06/202316:06EDGAR2Form 8-K - Current report
      11/06/202316:05GLOBEOPKO Health Reports Third Quarter 2023 Business Highlights..
      11/02/202310:00GLOBENew Clinical Data on OPKO Health’s RAYALDEE® (ER..
      10/31/202316:08EDGAR2Form 8-K/A - Current report: [Amend]
      10/31/202308:00GLOBEOPKO Health to Report Third Quarter 2023 Financial Results..
      10/25/202316:25GLOBEOPKO Health to Present New Clinical Data on Rayaldee (ER..
      9/28/202317:10DJNModeX Therapeutics Awarded Contract to Address Public Health..
      9/28/202316:09EDGAR2Form 8-K - Current report
      9/28/202316:08GLOBEModeX Therapeutics Secures BARDA Contract to Develop Novel..
      9/12/202308:30GLOBEEntera Bio Announces Collaboration with OPKO Biologics to..
      8/03/202316:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/03/202316:07EDGAR2Form 8-K - Current report
      8/03/202316:05GLOBEOPKO Health Reports Second Quarter 2023 Business Highlights..
      7/25/202316:05GLOBEOPKO Health to Report Second Quarter 2023 Financial Results..
      6/30/202316:10EDGAR2Form 8-K - Current report
      6/28/202306:45BWFDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly..
      5/03/202316:05GLOBEOPKO Health Reports First Quarter 2023 Business Highlights..

      Your Recent History

      NASDAQ
      OPK
      Opko Health
      Delayed Upgrade Clock